HDAC1 and acute myeloid leukemia: To detect the potential mechanism underlying the higher level of HDAC1 in drug-resistant AML cells, we first compared the differential expression of HDAC1 in nondrug-resistant AML cells and drug-resistant AML cells incubated with cycloheximide (CHX), a protein synthesis inhibitor (Fig. 5).